Preclinical, pharmacologic, and phase I studies of gemcitabine

Seminars in Oncology

Volumn 24, Issue 2 SUPPL. 7, 1997, Pages

  Storniolo, A M ^a   Allerheiligen, S R B ^a   Pearce, H L ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE;

ANTINEOPLASTIC ACTIVITY; BONE MARROW SUPPRESSION; CLINICAL TRIAL; CONFERENCE PAPER; DNA REPLICATION; DOSE RESPONSE; DRUG CLEARANCE; DRUG DNA INTERACTION; DRUG EXCRETION; DRUG HALF LIFE; FEMALE; FLU LIKE SYNDROME; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SOLID TUMOR;

EID: 0030996052     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)